Scholarlink

Purpose <p>Unilateral vocal fold paralysis (UVFP), resulting from recurrent laryngeal nerve injury, significantly impairs phonation and reduces quality of life. Laryngeal reinnervation, including ansa-to-recurrent (ansaNSR) and nerve-muscle pedicle reinnervation combined with arytenoid adduction (NMPR + AA), has gained attention as a durable treatment option. This systematic review aims to evaluate the outcomes of laryngeal reinnervation, identify predictive factors and highlight knowledge gaps relevant to clinical practice.</p> Methods <p>A systematic search of PubMed, Embase, Web of Science, the Cochrane Library and Emcare identified 42 studies. Outcome measures included perceptual, acoustic, aerodynamic, videostroboscopic and patient-reported outcomes. The risk of bias was assessed using the Methodological Index for Non-Randomized Studies (MINORS) tool. Weighted mean improvements were calculated for clinically relevant parameters.</p> Results <p>We included forty-two studies (<i>N</i> = 1 859 patients) in our review. These studies demonstrated high rates of voice improvement, primarily based on data from the ansaNSR (<i>N</i> = 1 369) and NMPR + AA (<i>N</i> = 278) techniques. Age and duration of denervation emerged as the most influential predictive factor. Younger patients (&lt; 60 years) and those with shorter denervation periods (&lt; 2 years) had better outcomes, although successful results were also observed beyond these thresholds. The predictive value of preoperative laryngeal electromyography (LEMG), etiology of UVFP and clinical presentation remains inconclusive.</p> Conclusion <p>Laryngeal reinnervation (ansaNSR and NMPR + AA) is effective for UVFP, offering durable voice improvements with minimal complication rates. Future research should focus on standardizing outcome measurements, clarifying predictive factors and refining patient selection to enhance clinical decision-making.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Laryngeal reinnervation for unilateral vocal fold paralysis in adults; a systematic review of the literature for the clinician

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月15日

查看全文
  • Stephanie D. Mes,
  • Bas J. Heijnen,
  • Martine H. Hendriksma,
  • Antonius P.M Langeveld,
  • Emilie A.C. Dronkers,
  • Elisabeth V. Sjögren

摘要

Purpose

Unilateral vocal fold paralysis (UVFP), resulting from recurrent laryngeal nerve injury, significantly impairs phonation and reduces quality of life. Laryngeal reinnervation, including ansa-to-recurrent (ansaNSR) and nerve-muscle pedicle reinnervation combined with arytenoid adduction (NMPR + AA), has gained attention as a durable treatment option. This systematic review aims to evaluate the outcomes of laryngeal reinnervation, identify predictive factors and highlight knowledge gaps relevant to clinical practice.

Methods

A systematic search of PubMed, Embase, Web of Science, the Cochrane Library and Emcare identified 42 studies. Outcome measures included perceptual, acoustic, aerodynamic, videostroboscopic and patient-reported outcomes. The risk of bias was assessed using the Methodological Index for Non-Randomized Studies (MINORS) tool. Weighted mean improvements were calculated for clinically relevant parameters.

Results

We included forty-two studies (N = 1 859 patients) in our review. These studies demonstrated high rates of voice improvement, primarily based on data from the ansaNSR (N = 1 369) and NMPR + AA (N = 278) techniques. Age and duration of denervation emerged as the most influential predictive factor. Younger patients (< 60 years) and those with shorter denervation periods (< 2 years) had better outcomes, although successful results were also observed beyond these thresholds. The predictive value of preoperative laryngeal electromyography (LEMG), etiology of UVFP and clinical presentation remains inconclusive.

Conclusion

Laryngeal reinnervation (ansaNSR and NMPR + AA) is effective for UVFP, offering durable voice improvements with minimal complication rates. Future research should focus on standardizing outcome measurements, clarifying predictive factors and refining patient selection to enhance clinical decision-making.